The price of Sabra Healthcare REIT Inc (NASDAQ: SBRA) closed at $13.78 in the last session, down -3.70% from day before closing price of $14.31. In other words, the price has decreased by -$0.53 from its previous closing price. On the day, 2012704 shares were traded.
Ratios:
We take a closer look at SBRA’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 68.27 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 10.59. In the meantime, Its Debt-to-Equity ratio is 0.87 whereas as Long-Term Debt/Eq ratio is at 0.80.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Deutsche Bank on January 30, 2024, initiated with a Buy rating and assigned the stock a target price of $21.
On October 17, 2023, BMO Capital Markets Downgraded its rating to Market Perform which previously was Outperform but kept the price unchanged to $16.
Wells Fargo Upgraded its Underweight to Equal Weight on October 16, 2023, whereas the target price for the stock was revised from $13 to $15.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 01 ’23 when Costa Michael Lourenco bought 1,947 shares for $12.63 per share. The transaction valued at 24,591 led to the insider holds 183,218 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SBRA now has a Market Capitalization of 3.31B and an Enterprise Value of 5.68B. As of this moment, Sabra’s Price-to-Earnings (P/E) ratio for their current fiscal year is 235.96, and their Forward P/E ratio for the next fiscal year is 21.40. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 32.32. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.88 while its Price-to-Book (P/B) ratio in mrq is 1.14. Its current Enterprise Value per Revenue stands at 8.78 whereas that against EBITDA is 18.23.
Stock Price History:
Over the past 52 weeks, SBRA has reached a high of $14.91, while it has fallen to a 52-week low of $10.10. The 50-Day Moving Average of the stock is 13.97, while the 200-Day Moving Average is calculated to be 13.60.
Shares Statistics:
According to the various share statistics, SBRA traded on average about 2.09M shares per day over the past 3-months and 1.9M shares per day over the past 10 days. A total of 231.27M shares are outstanding, with a floating share count of 227.78M. Insiders hold about 1.60% of the company’s shares, while institutions hold 92.05% stake in the company. Shares short for SBRA as of Mar 28, 2024 were 11.19M with a Short Ratio of 5.36, compared to 12.75M on Feb 29, 2024. Therefore, it implies a Short% of Shares Outstanding of 4.83% and a Short% of Float of 6.94%.
Dividends & Splits
The forward annual dividend rate for SBRA is 0.81, which was 1.20 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 8.39%, it implies a Forward Annual Dividend Yield of 8.71%. The stock’s 5-year Average Dividend Yield is 9.06. The current Payout Ratio is 2030.46% for SBRA, which recently paid a dividend on Feb 29, 2024 with an ex-dividend date of Feb 12, 2024. Stock splits for the company last occurred on Nov 16, 2010 when the company split stock in a 1:3 ratio.
